Production (Stage)
Tectonic Therapeutic, Inc.
TECX
$21.65
-$0.55-2.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.50% | -57.24% | -76.22% | -21.20% | -5.37% |
| Total Depreciation and Amortization | -4.51% | 36.19% | 14.29% | -9.19% | 3.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.83% | 258.44% | 252.16% | 305.62% | 389.98% |
| Change in Net Operating Assets | -105.24% | -49.36% | -760.84% | -1,585.13% | 6.04% |
| Cash from Operations | -41.09% | -44.30% | -131.15% | -37.56% | 14.26% |
| Capital Expenditure | -575.00% | 94.00% | -2,085.71% | 104.65% | 97.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -575.00% | 94.00% | -2,085.71% | 104.65% | 97.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -5.26% | 3.17% | 18.06% |
| Issuance of Common Stock | 4,455,900.00% | -- | -- | -- | 300.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 26,764.97% | -103.13% | -5,414.91% | 142,749.21% | -367.13% |
| Foreign Exchange rate Adjustments | 93.42% | 131.25% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,746.61% | -179.58% | -202.59% | 1,773.80% | 9.67% |